Cargando…

Changing epidemiology of cirrhosis from 2010 to 2019: results from the Global Burden Disease study 2019

BACKGROUND: Liver cirrhosis is a significant yet largely preventable and underappreciated cause of global health loss. This study aimed to profile the global and regional burdens of liver cirrhosis between 2010 and 2019 and the contributions of various aetiologies. METHOD: Data on the incidence, mor...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Shiyu, Xie, Wenhui, Zhang, Yinghui, Lei, Lei, Pan, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469427/
https://www.ncbi.nlm.nih.gov/pubmed/37647379
http://dx.doi.org/10.1080/07853890.2023.2252326
_version_ 1785099438089306112
author Xiao, Shiyu
Xie, Wenhui
Zhang, Yinghui
Lei, Lei
Pan, Yan
author_facet Xiao, Shiyu
Xie, Wenhui
Zhang, Yinghui
Lei, Lei
Pan, Yan
author_sort Xiao, Shiyu
collection PubMed
description BACKGROUND: Liver cirrhosis is a significant yet largely preventable and underappreciated cause of global health loss. This study aimed to profile the global and regional burdens of liver cirrhosis between 2010 and 2019 and the contributions of various aetiologies. METHOD: Data on the incidence, mortality, and disability-adjusted life years (DALYs) of cirrhosis were obtained from the Global Burden of Disease 2019 study. The burden of cirrhosis was estimated by age, sex, region, aetiology, and socio-demographic index (SDI). The temporal trend was quantified using the annual percentage changes (APC.) RESULTS: Globally, there were 2.05 million new cases and 1.47 million deaths due to cirrhosis in 2019. From 2010 to 2019, the age-standardized incidence rate (ASIR) for cirrhosis increased slightly from 25.19 to 25.35 worldwide, while the age-standardized death rate (ASDR) and age-standardized DALYs (ASDALYs) decreased from 20.37 to 18.00 and 639.86 to 560.43, respectively. Cirrhosis incidence, mortality and DALYs were consistently higher in males than females. Stratification according to the socio-demographic index (SDI) revealed that low SDI countries had the highest ASDR and ASDALYs in 2019, while middle SDI countries had the highest ASIR. Regarding the aetiology of cirrhosis, hepatitis C accounted for the largest proportion of cirrhosis-related incidence (26.9%), death (26.8%) and DALYs (26.3%); however, non-alcoholic fatty liver disease (NAFLD) exhibited a rapidly growing cause of incident cirrhosis (+26.7%), cirrhosis-related death (+25.1%), and DALYs (+21.0%) worldwide during this period. The ASIR for NAFLD also significantly increased with APC 1.080 over the study period. CONCLUSIONS: Albeit the global burden of cirrhosis incidence increased from 2010 to 2019, cirrhosis-associated deaths and DALYs declined significantly. Notably, NAFLD exhibited the most significant increase as a contributor to cirrhosis worldwide.
format Online
Article
Text
id pubmed-10469427
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-104694272023-09-01 Changing epidemiology of cirrhosis from 2010 to 2019: results from the Global Burden Disease study 2019 Xiao, Shiyu Xie, Wenhui Zhang, Yinghui Lei, Lei Pan, Yan Ann Med Gastroenterology & Hepatology BACKGROUND: Liver cirrhosis is a significant yet largely preventable and underappreciated cause of global health loss. This study aimed to profile the global and regional burdens of liver cirrhosis between 2010 and 2019 and the contributions of various aetiologies. METHOD: Data on the incidence, mortality, and disability-adjusted life years (DALYs) of cirrhosis were obtained from the Global Burden of Disease 2019 study. The burden of cirrhosis was estimated by age, sex, region, aetiology, and socio-demographic index (SDI). The temporal trend was quantified using the annual percentage changes (APC.) RESULTS: Globally, there were 2.05 million new cases and 1.47 million deaths due to cirrhosis in 2019. From 2010 to 2019, the age-standardized incidence rate (ASIR) for cirrhosis increased slightly from 25.19 to 25.35 worldwide, while the age-standardized death rate (ASDR) and age-standardized DALYs (ASDALYs) decreased from 20.37 to 18.00 and 639.86 to 560.43, respectively. Cirrhosis incidence, mortality and DALYs were consistently higher in males than females. Stratification according to the socio-demographic index (SDI) revealed that low SDI countries had the highest ASDR and ASDALYs in 2019, while middle SDI countries had the highest ASIR. Regarding the aetiology of cirrhosis, hepatitis C accounted for the largest proportion of cirrhosis-related incidence (26.9%), death (26.8%) and DALYs (26.3%); however, non-alcoholic fatty liver disease (NAFLD) exhibited a rapidly growing cause of incident cirrhosis (+26.7%), cirrhosis-related death (+25.1%), and DALYs (+21.0%) worldwide during this period. The ASIR for NAFLD also significantly increased with APC 1.080 over the study period. CONCLUSIONS: Albeit the global burden of cirrhosis incidence increased from 2010 to 2019, cirrhosis-associated deaths and DALYs declined significantly. Notably, NAFLD exhibited the most significant increase as a contributor to cirrhosis worldwide. Taylor & Francis 2023-08-30 /pmc/articles/PMC10469427/ /pubmed/37647379 http://dx.doi.org/10.1080/07853890.2023.2252326 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
spellingShingle Gastroenterology & Hepatology
Xiao, Shiyu
Xie, Wenhui
Zhang, Yinghui
Lei, Lei
Pan, Yan
Changing epidemiology of cirrhosis from 2010 to 2019: results from the Global Burden Disease study 2019
title Changing epidemiology of cirrhosis from 2010 to 2019: results from the Global Burden Disease study 2019
title_full Changing epidemiology of cirrhosis from 2010 to 2019: results from the Global Burden Disease study 2019
title_fullStr Changing epidemiology of cirrhosis from 2010 to 2019: results from the Global Burden Disease study 2019
title_full_unstemmed Changing epidemiology of cirrhosis from 2010 to 2019: results from the Global Burden Disease study 2019
title_short Changing epidemiology of cirrhosis from 2010 to 2019: results from the Global Burden Disease study 2019
title_sort changing epidemiology of cirrhosis from 2010 to 2019: results from the global burden disease study 2019
topic Gastroenterology & Hepatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469427/
https://www.ncbi.nlm.nih.gov/pubmed/37647379
http://dx.doi.org/10.1080/07853890.2023.2252326
work_keys_str_mv AT xiaoshiyu changingepidemiologyofcirrhosisfrom2010to2019resultsfromtheglobalburdendiseasestudy2019
AT xiewenhui changingepidemiologyofcirrhosisfrom2010to2019resultsfromtheglobalburdendiseasestudy2019
AT zhangyinghui changingepidemiologyofcirrhosisfrom2010to2019resultsfromtheglobalburdendiseasestudy2019
AT leilei changingepidemiologyofcirrhosisfrom2010to2019resultsfromtheglobalburdendiseasestudy2019
AT panyan changingepidemiologyofcirrhosisfrom2010to2019resultsfromtheglobalburdendiseasestudy2019